N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide
| CAS No. | 728865-23-4 |
|---|---|
| MDL No. | MFCD22665727 |
| MF | C24H27N3O5 |
| MW | 437.50 |
| InChI Key | FQYBTYFKOHPWQT-VGSWGCGISA-N |
| CAS No. | 728865-23-4 |
|---|---|
| MDL No. | MFCD22665727 |
| MF | C24H27N3O5 |
| MW | 437.50 |
| InChI Key | FQYBTYFKOHPWQT-VGSWGCGISA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
CHIR-090 is an L-threonine derivative formed by the formal condensation of the carboxy group of 4-({4-[(morpholin-4-yl)methyl]phenyl}ethynyl)benzoic acid with the amino group of N-hydroxy-L-threoninamide. It functions as an antimicrobial agent, a lipopolysaccharide biosynthesis inhibitor, and an inhibitor of EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase). It is an acetylenic compound, a morpholine, a benzamide, a L-threonine derivative, and a hydroxamic acid.
| CAS No. | 728865-23-4 |
|---|---|
| Product Name | N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide |
| Heavy Atom Count | 32 | Rotatable Bond Count | 6 |
| Atom Stereo Count | 2 | Bond Stereo Count | 0 |
| HBA | 6 | HBD | 4 |
| TPSA | 111.130 Ų | Charge | 0 |
| Exact Mass | 437.19507 | Complexity | 971.43 |
| pKa | 7.130 | XLogP | 0.903 |